A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged ≥10 to <19 Years

Clinical trial NCT01830855 · COMPLETED

Trial details

NCT number: NCT01830855
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Meningococcal Vaccine

Start date: 2013-04-01
Primary completion: 2015-04-01
Enrollment: 3596

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.